LIPOCINE INC. Net Income (Loss) Available to Common Stockholders, Diluted
LIPOCINE INC. (LPCN) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$2.62 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-04
- LIPOCINE INC. net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was -$2.62M.
- LIPOCINE INC. net income (loss) available to common stockholders, diluted for the quarter ending 2026-03-31 was -$3.67M.
- LIPOCINE INC. net income (loss) available to common stockholders, diluted for the quarter ending 2025-12-31 was -$2.37M, a 233.26% decline year-over-year.
- LIPOCINE INC. net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-30 was -$3.19M.
- LIPOCINE INC. net income (loss) available to common stockholders, diluted for fiscal 2025 was -$9.63M.
- LIPOCINE INC. net income (loss) available to common stockholders, diluted for fiscal 2024 was -$8.81K.
- LIPOCINE INC. net income (loss) available to common stockholders, diluted for fiscal 2023 was -$16.56M.
- LIPOCINE INC. net income (loss) available to common stockholders, diluted for fiscal 2022 was -$11.32M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 12 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.62M 10-Q · filed 2026-08-04 | -$6.29M 10-Q · filed 2026-08-04 | -$8.66M derived: sum of 3 quarters · filed 2026-08-04 | -$11.85M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | -$3.67M 10-Q · filed 2026-05-07 | -$6.04M derived: sum of 2 quarters · filed 2026-05-07 | -$9.23M derived: sum of 3 quarters · filed 2026-05-07 | -$11.43M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$5.56M derived: sum of 2 quarters · filed 2026-03-10 | -$7.76M derived: sum of 3 quarters · filed 2026-08-04 | -$9.63M 10-K · filed 2026-03-10 | ||||
| 2025-09-30 | -$3.19M 10-Q · filed 2025-11-06 | -$5.39M derived: sum of 2 quarters · filed 2026-08-04 | -$7.26M 10-Q · filed 2025-11-06 | -$5.48M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | -$2.21M 10-Q · filed 2026-08-04 | -$4.07M 10-Q · filed 2026-08-04 | -$2.29M derived: sum of 3 quarters · filed 2026-08-04 | -$4.65M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | -$1.86M 10-Q · filed 2026-05-07 | -$86.28K derived: sum of 2 quarters · filed 2026-05-07 | -$2.44M derived: sum of 3 quarters · filed 2026-05-07 | -$5.43M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$578.30K derived: sum of 2 quarters · filed 2026-03-10 | -$3.56M derived: sum of 3 quarters · filed 2026-03-10 | -$8.81K 10-K · filed 2026-03-10 | ||||
| 2024-09-30 | -$2.36M 10-Q · filed 2025-11-06 | -$5.34M derived: sum of 2 quarters · filed 2025-11-06 | -$1.79M 10-Q · filed 2025-11-06 | -$4.08M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | -$2.98M 10-Q · filed 2025-08-05 | $569.49K 10-Q · filed 2025-08-05 | -$1.73M derived: sum of 3 quarters · filed 2025-08-05 | -$8.45M derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | $3.55M 10-Q · filed 2025-05-08 | $1.26M derived: sum of 2 quarters · filed 2025-05-08 | -$5.47M derived: sum of 3 quarters · filed 2025-05-08 | -$9.04M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | -$2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$9.02M derived: sum of 2 quarters · filed 2025-03-13 | -$12.60M derived: sum of 3 quarters · filed 2025-03-13 | -$16.56M 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | -$6.73M 10-Q · filed 2024-11-07 | -$10.30M derived: sum of 2 quarters · filed 2024-11-07 | -$14.27M 10-Q · filed 2024-11-07 | -$16.53M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | -$3.58M 10-Q · filed 2024-08-08 | -$7.54M 10-Q · filed 2024-08-08 | -$7.54M 10-Q · filed 2023-08-10 | -$9.81M derived: sum of 3 quarters · filed 2024-08-08 | -$12.54M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | -$3.97M 10-Q · filed 2024-05-09 | -$3.97M 10-Q · filed 2023-05-11 | -$6.23M derived: sum of 2 quarters · filed 2024-05-09 | -$8.97M derived: sum of 3 quarters · filed 2024-05-09 | -$12.18M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | -$2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$5.00M derived: sum of 2 quarters · filed 2024-03-07 | -$8.21M derived: sum of 3 quarters · filed 2024-03-07 | -$11.32M 10-K · filed 2024-03-07 | ||||
| 2022-09-30 | -$2.74M 10-Q · filed 2023-11-08 | -$5.95M derived: sum of 2 quarters · filed 2023-11-08 | -$9.06M 10-Q · filed 2023-11-08 | $3.34M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | -$3.22M 10-Q · filed 2023-08-10 | -$6.33M 10-Q · filed 2023-08-10 | $6.07M derived: sum of 3 quarters · filed 2023-08-10 | $2.51M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$3.49M 10-Q · filed 2023-05-11 | $9.29M derived: sum of 2 quarters · filed 2023-05-11 | $5.73M derived: sum of 3 quarters · filed 2023-05-11 | -$1.31M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $12.77M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $9.21M derived: sum of 2 quarters · filed 2023-03-10 | $2.18M derived: sum of 3 quarters · filed 2023-03-10 | -$990.29K 10-K · filed 2023-03-10 | -$634.40K 10-K · filed 2022-03-09 | |||
| 2021-09-30 | -$3.56M 10-Q · filed 2022-11-09 | -$3.08M 10-Q · filed 2021-11-10 | -$10.59M derived: sum of 2 quarters · filed 2022-11-09 | -$13.76M 10-Q · filed 2022-11-09 | -$13.26M 10-Q · filed 2021-11-10 | -$18.47M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | -$7.03M 10-Q · filed 2022-08-08 | -$6.81M 10-Q · filed 2021-08-05 | -$10.20M 10-Q · filed 2022-08-08 | -$10.18M 10-Q · filed 2021-08-05 | -$14.91M derived: sum of 3 quarters · filed 2022-08-08 | -$19.22M derived: sum of 4 quarters · filed 2022-08-08 | ||
| 2021-03-31 | -$3.37M 10-Q · filed 2022-05-09 | -$7.88M derived: sum of 2 quarters · filed 2022-05-09 | -$12.19M derived: sum of 3 quarters · filed 2022-05-09 | -$18.56M derived: sum of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | -$4.51M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | -$8.82M derived: sum of 2 quarters · filed 2022-03-09 | -$15.19M derived: sum of 3 quarters · filed 2022-03-09 | -$20.96M 10-K · filed 2022-03-09 | ||||
| 2020-09-30 | -$4.31M 10-Q · filed 2021-11-10 | -$10.68M derived: sum of 2 quarters · filed 2021-11-10 | -$16.45M 10-Q · filed 2021-11-10 | -$19.75M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | -$6.37M 10-Q · filed 2021-08-05 | -$12.14M 10-Q · filed 2021-08-05 | -$15.43M derived: sum of 3 quarters · filed 2021-08-05 | -$18.49M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | -$5.77M 10-Q · filed 2021-05-06 | -$9.06M derived: sum of 2 quarters · filed 2021-05-06 | -$12.12M derived: sum of 3 quarters · filed 2021-05-06 | -$15.55M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | -$3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$6.35M derived: sum of 2 quarters · filed 2021-03-11 | -$9.78M derived: sum of 3 quarters · filed 2021-03-11 | -$13.01M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | -$3.06M 10-Q · filed 2020-11-10 | -$6.49M derived: sum of 2 quarters · filed 2020-11-10 | -$9.72M 10-Q · filed 2020-11-10 | -$12.94M derived: sum of 4 quarters · filed 2020-11-10 | ||||
| 2019-06-30 | -$3.43M 10-Q · filed 2020-08-06 | -$6.66M 10-Q · filed 2020-08-06 | -$9.88M derived: sum of 3 quarters · filed 2020-08-06 | -$12.34M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$3.22M 10-Q · filed 2020-05-07 | -$6.45M derived: sum of 2 quarters · filed 2020-05-07 | -$8.91M derived: sum of 3 quarters · filed 2020-05-07 | -$12.16M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$5.68M derived: sum of 2 quarters · filed 2020-03-13 | -$8.94M derived: sum of 3 quarters · filed 2020-03-13 | -$11.66M 10-K · filed 2020-03-13 | ||||
| 2018-09-30 | -$2.46M 10-Q · filed 2019-11-12 | -$5.71M derived: sum of 2 quarters · filed 2019-11-12 | -$8.43M 10-Q · filed 2019-11-12 | -$13.77M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | -$3.26M 10-Q · filed 2019-08-07 | -$3.26M 10-Q · filed 2018-08-07 | -$5.98M 10-Q · filed 2019-08-07 | -$11.31M derived: sum of 3 quarters · filed 2019-08-07 | -$16.01M derived: sum of 4 quarters · filed 2019-08-07 | |||
| 2018-03-31 | -$2.72M 10-Q · filed 2019-05-08 | -$8.05M derived: sum of 2 quarters · filed 2019-05-08 | -$12.75M derived: sum of 3 quarters · filed 2019-05-08 | -$18.84M derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2017-12-31 | -$5.33M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$10.03M derived: sum of 2 quarters · filed 2019-03-06 | -$16.12M derived: sum of 3 quarters · filed 2019-03-06 | -$20.98M 10-K · filed 2019-03-06 | ||||
| 2017-09-30 | -$4.70M 10-Q · filed 2018-11-07 | -$10.79M derived: sum of 2 quarters · filed 2018-11-07 | -$15.65M 10-Q · filed 2018-11-07 | -$18.62M derived: sum of 4 quarters · filed 2019-03-06 | ||||
| 2017-06-30 | -$6.09M 10-Q · filed 2018-08-07 | -$10.95M 10-Q · filed 2018-08-07 | -$13.92M derived: sum of 3 quarters · filed 2019-03-06 | -$17.15M derived: sum of 4 quarters · filed 2019-03-06 | ||||
| 2017-03-31 | -$4.86M 10-Q · filed 2018-05-07 | -$7.83M derived: sum of 2 quarters · filed 2019-03-06 | -$11.06M derived: sum of 3 quarters · filed 2019-03-06 | -$16.82M derived: sum of 4 quarters · filed 2019-03-06 | ||||
| 2016-12-31 | -$2.97M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$6.20M derived: sum of 2 quarters · filed 2019-03-06 | -$11.96M derived: sum of 3 quarters · filed 2019-03-06 | -$18.97M 10-K · filed 2019-03-06 | ||||
| 2016-09-30 | -$3.24M 10-Q · filed 2017-11-08 | -$9.00M derived: sum of 2 quarters · filed 2017-11-08 | -$16.01M 10-Q · filed 2017-11-08 | -$20.64M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-06-30 | -$5.76M 10-Q · filed 2017-08-07 | -$12.77M 10-Q · filed 2017-08-07 | -$17.40M derived: sum of 3 quarters · filed 2018-03-12 | -$23.78M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-03-31 | -$7.01M 10-Q · filed 2017-05-08 | -$11.64M derived: sum of 2 quarters · filed 2018-03-12 | -$18.02M derived: sum of 3 quarters · filed 2018-03-12 | -$22.26M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2015-12-31 | -$4.63M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$11.01M derived: sum of 2 quarters · filed 2018-03-12 | -$15.25M derived: sum of 3 quarters · filed 2018-03-12 | -$18.21M 10-K · filed 2018-03-12 | ||||
| 2015-09-30 | -$6.37M 10-Q · filed 2016-11-08 | -$10.62M derived: sum of 2 quarters · filed 2016-11-08 | -$13.57M 10-Q · filed 2016-11-08 | -$17.61M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2015-06-30 | -$4.25M 10-Q · filed 2016-08-09 | -$7.20M 10-Q · filed 2016-08-09 | -$11.24M derived: sum of 3 quarters · filed 2017-03-06 | -$15.34M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2015-03-31 | -$2.96M 10-Q · filed 2016-05-09 | -$7.00M derived: sum of 2 quarters · filed 2017-03-06 | -$11.09M derived: sum of 3 quarters · filed 2017-03-06 | -$18.06M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2014-12-31 | -$4.04M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | -$8.13M derived: sum of 2 quarters · filed 2017-03-06 | -$15.11M derived: sum of 3 quarters · filed 2017-03-06 | -$20.37M 10-K · filed 2017-03-06 | ||||
| 2014-09-30 | -$4.09M 10-Q · filed 2015-11-12 | -$11.07M derived: sum of 2 quarters · filed 2015-11-12 | -$16.33M 10-Q · filed 2015-11-12 | -$20.72M derived: sum of 4 quarters · filed 2015-11-12 | ||||
| 2014-06-30 | -$6.97M 10-Q · filed 2015-08-11 | -$12.24M 10-Q · filed 2015-08-11 | -$16.63M derived: sum of 3 quarters · filed 2015-08-11 | -$20.10M derived: sum of 4 quarters · filed 2015-08-11 | ||||
| 2014-03-31 | -$5.27M 10-Q · filed 2015-05-07 | -$9.66M derived: sum of 2 quarters · filed 2015-05-07 | -$13.13M derived: sum of 3 quarters · filed 2015-05-07 | -$14.51M derived: sum of 4 quarters · filed 2015-05-07 | ||||
| 2013-12-31 | -$4.39M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | -$7.87M derived: sum of 2 quarters · filed 2015-03-11 | -$9.24M derived: sum of 3 quarters · filed 2015-03-11 | -$10.59M 10-K · filed 2015-03-11 | ||||
| 2013-09-30 | -$3.48M 10-Q · filed 2014-11-10 | -$4.85M derived: sum of 2 quarters · filed 2014-11-10 | -$6.20M 10-Q · filed 2014-11-10 | -$7.06M derived: sum of 4 quarters · filed 2014-11-10 | ||||
| 2013-06-30 | -$1.37M 10-Q · filed 2014-08-13 | -$2.72M 10-Q · filed 2014-08-13 | -$3.58M derived: sum of 3 quarters · filed 2014-08-13 | -$4.59M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2013-03-31 | -$1.35M 10-Q · filed 2014-05-13 | -$2.21M derived: sum of 2 quarters · filed 2014-05-13 | -$3.22M derived: sum of 3 quarters · filed 2014-05-13 | |||||
| 2012-12-31 | -$855.91K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$1.87M derived: sum of 2 quarters · filed 2014-03-31 | $3.80M 10-K · filed 2014-03-31 | |||||
| 2012-09-30 | -$1.01M 10-Q · filed 2013-11-13 | $4.66M 10-Q · filed 2013-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |